Farhad Ravandi (Farhad Ravandi-Kashani)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 90

Top Topics

Newly Diagnosed

Tyrosine Kinase

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

American journal of hematology

Blood cancer journal

Leukemia & lymphoma

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Siddiqui, Sergej Konoplev, Ghayas C Issa, Hagop M Kantarjian, Naval G Daver, Farhad Ravandi, Tapan Mahendra Kadia, Guillin Tang, Sa A Wang, Beenu Thakral, L Jeffrey Medeiros, Olga Pozdnyakova, Sherry Pierce, Guillermo Montalban-Bravo, Kelly Sharon Chien, Danielle Hammond, Koiji Sasaki, Guillermo Garcia-Manero, Robert P Hasserjian
Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements. American journal of hematology (2023)
Maria Siddiqui, Sergej Konoplev, Ghayas C Issa, Hagop M Kantarjian, Naval G Daver, Farhad Ravandi, Tapan Mahendra Kadia, Guillin Tang, Sa A Wang, Beenu Thakral, L Jeffrey Medeiros, Olga Pozdnyakova, Sherry Pierce, Guillermo Montalban-Bravo, Kelly Sharon Chien, Danielle Hammond, Koiji Sasaki, Guillermo Garcia-Manero, Robert P Hasserjian
Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements. American journal of hematology 98 (4) (2023)
Hagop M Kantarjian, Nicholas James Short, Nitin Jain, Koji Sasaki, Xuelin Huang, Fady Gh Haddad, Issa F Khouri, Courtney D Di Nardo, Naveen Pemmaraju, William Wierda, Guillermo Garcia Manero, Partow Kebriaei, Rebecca Garris, Sanam Loghavi, Jeffrey Jorgensen, Monica Kwari, Susan O'Brien, Farhad Ravandi, Elias J Jabbour
Frontline combination of ponatinib and hyper-CVAD in Philadelphia chromosome-positive acute lymphoblastic leukemia: 80-months follow-up results. American journal of hematology 98 (3) (2023)
Farhad Ravandi, Jacqueline Cloos, Francesco Buccisano, Richard Dillon, Konstanze Döhner, Sylvie D Freeman, Christopher S Hourigan, Gerrit J Ossenkoppele, Gail J Roboz, Marion Subklewe, Christian Thiede, Isabell Arnhardt, Peter J M Valk, Adriano Venditti, Andrew H Wei, Roland B Walter, Michael Heuser
Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower-intensity therapy: Roadmap from an ELN-DAVID expert panel. American journal of hematology (2023)
Tapan Mahendra Kadia, Farhad Ravandi, Matteo Molica, Alex Bataller, Gautam Borthakur, Naval G Daver, Elias J Jabbour, Courtney D Di Nardo, Naveen Pemmaraju, Nitin Jain, Alessandra Ferrajoli, Musa Ylimaz, Prithviraj Bose, Rebecca S Slack Tidwell, Kayleigh R Marx, Caitlin R Rausch, Rashmi Kanagal-Shamana, Sa A Wang, Rabiul Islam, Richard Champlin, Elizabeth Shpall, Marina Y Konopleva, Guillermo Garcia Manero, Hagop M Kantarjian
Phase II study of cladribine, idarubicin, and ara-C (CLIA) with or without sorafenib as initial therapy for patients with acute myeloid leukemia. American journal of hematology (2023)
Rodrick Babakhanlou, Farhad Ravandi
Non-intensive acute myeloid leukemia therapies for older patients. Expert review of hematology (2023)
Timothy Anthony Yap, Naval G Daver, Mikhila Mahendra, Jixiang Zhang, Carlos Kamiya-Matsuoka, Funda Meric-Bernstam, Hagop M Kantarjian, Farhad Ravandi, Meghan E Collins, Maria Emilia Di Francesco, Ecaterina E Dumbrava, Siqing Fu, Sisi Gao, Jason P Gay, Sonal Gera, Jing Han, David S Hong, Elias J Jabbour, Zhenlin Ju, Daniel D Karp, Alessia Lodi, Jennifer R Molina, Natalia Baran, Aung Naing, Maro Ohanian, Shubham Pant, Naveen Pemmaraju, Prithviraj Bose, Sarina A Piha-Paul, Jordi Rodon, Carolina Salguero, Koiji Sasaki, Anand K Singh, Vivek Subbiah, Apostolia M Tsimberidou, Quanyun A Xu, Musa Ylimaz, Qi Zhang, Yuan Li, Christopher A Bristow, Meenakshi B Bhattacharjee, Stefano Tiziani, Timothy P Heffernan, Christopher P Vellano, Philip Jones, Cobi J Heijnen, Annemieke Kavelaars, Joseph R Marszalek, Marina Y Konopleva
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nature medicine 29 (1) (2023)
Timothy Anthony Yap, Naval G Daver, Mikhila Mahendra, Jixiang Zhang, Carlos Kamiya-Matsuoka, Funda Meric-Bernstam, Hagop M Kantarjian, Farhad Ravandi, Meghan E Collins, Maria Emilia Di Francesco, Ecaterina E Dumbrava, Siqing Fu, Sisi Gao, Jason P Gay, Sonal Gera, Jing Han, David S Hong, Elias J Jabbour, Zhenlin Ju, Daniel D Karp, Alessia Lodi, Jennifer R Molina, Natalia Baran, Aung Naing, Maro Ohanian, Shubham Pant, Naveen Pemmaraju, Prithviraj Bose, Sarina A Piha-Paul, Jordi Rodon, Carolina Salguero, Koiji Sasaki, Anand K Singh, Vivek Subbiah, Apostolia M Tsimberidou, Quanyun A Xu, Musa Ylimaz, Qi Zhang, Yuan Li, Christopher A Bristow, Meenakshi B Bhattacharjee, Stefano Tiziani, Timothy P Heffernan, Christopher P Vellano, Philip Jones, Cobi J Heijnen, Annemieke Kavelaars, Joseph R Marszalek, Marina Y Konopleva
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nature medicine (2023)
Curtis A Lachowiez, Sanam Loghavi, Zhihong Zeng, Tomoyuki Tanaka, Yi June Kim, Hidetaka Uryu, Sven Turkalj, Niels Asger Jakobsen, Marlise R Luskin, Dzifa Y Duose, Rebecca S Slack Tidwell, Nicholas James Short, Gautam Borthakur, Tapan Mahendra Kadia, Lucia Masarova, George D Tippett, Prithviraj Bose, Elias J Jabbour, Farhad Ravandi, Naval G Daver, Guillermo Garcia Manero, Hagop M Kantarjian, Jacqueline S Garcia, Paresh Vyas, Koichi Takahashi, Marina Y Konopleva, Courtney D Di Nardo
A phase Ib/II study of ivosidenib with venetoclax +/- azacitidine in IDH1-mutated myeloid malignancies. Blood cancer discovery (2023)
Timothy Anthony Yap, Naval G Daver, Mikhila Mahendra, Jixiang Zhang, Carlos Kamiya-Matsuoka, Funda Meric-Bernstam, Hagop M Kantarjian, Farhad Ravandi, Meghan E Collins, Maria Emilia Di Francesco, Ecaterina E Dumbrava, Siqing Fu, Sisi Gao, Jason P Gay, Sonal Gera, Jing Han, David S Hong, Elias J Jabbour, Zhenlin Ju, Daniel D Karp, Alessia Lodi, Jennifer R Molina, Natalia Baran, Aung Naing, Maro Ohanian, Shubham Pant, Naveen Pemmaraju, Prithviraj Bose, Sarina A Piha-Paul, Jordi Rodon, Carolina Salguero, Koiji Sasaki, Anand K Singh, Vivek Subbiah, Apostolia M Tsimberidou, Quanyun A Xu, Musa Ylimaz, Qi Zhang, Yuan Li, Christopher A Bristow, Meenakshi B Bhattacharjee, Stefano Tiziani, Timothy P Heffernan, Christopher P Vellano, Philip Jones, Cobi J Heijnen, Annemieke Kavelaars, Joseph R Marszalek, Marina Y Konopleva
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nature medicine 29 (1) (2023)
Andrew H Wei, Hartmut Döhner, Hamid Sayar, Farhad Ravandi, Pau Montesinos, Hervé Dombret, Dominik Selleslag, Kimmo Porkka, Jun-Ho Jang, Barry Skikne, C L Beach, Thomas Prebet, George Zhang, Alberto Risueño, Manuel Ugidos, Wendy L See, Daniel Menezes, Gail J Roboz
Long-term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo-controlled, phase 3 QUAZAR AML-001 trial. American journal of hematology (2023)
Farhad Ravandi, Hartmut Döhner, Andrew H Wei, Pau Montesinos, Michael Pfeilstöcker, Cristina Papayannidis, Yinzhi Lai, Kefeng Wang, Wendy L See, Daniel Lopes de Menezes, Erica Petrlik, Thomas Prebet, Gail J Roboz
Survival outcomes in patients with acute myeloid leukaemia who received subsequent therapy for relapse in QUAZAR AML-001. British journal of haematology (2023)
Danielle Hammond, Sanam Loghavi, Sa A Wang, Marina Y Konopleva, Tapan Mahendra Kadia, Naval G Daver, Maro Ohanian, Ghayas C Issa, Yesid Alvarado, Nicholas James Short, Koji Sasaki, Naveen Pemmaraju, Guillermo Montalban-Bravo, Curtis A Lachowiez, Abhishek Maiti, Guillermo Garcia Manero, Elias J Jabbour, Gautam Borthakur, Farhad Ravandi, Koichi Takahashi, Sherry R Pierce, Hagop M Kantarjian, Courtney D Di Nardo
Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents. Blood cancer journal 13 (1) (2023)
Jayastu Senapati, Muharrem Muftuoglu, Jo Ishizawa, Hussein A Abbas, Sanam Loghavi, Gautam Borthakur, Musa Ylimaz, Ghayas C Issa, Samuel I Dara, Mahesh Basyal, Li Li, Kiran Naqvi, Rasoul Pourebrahim, Elias J Jabbour, Steven M Kornblau, Nicholas James Short, Naveen Pemmaraju, Guillermo Garcia Manero, Farhad Ravandi, Joseph D Khoury, Naval G Daver, Hagop M Kantarjian, Michael Andreeff, Courtney D Di Nardo
A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis. Blood cancer journal 13 (1) (2023)
Hagop M Kantarjian, Nicholas James Short, Nitin Jain, Koji Sasaki, Xuelin Huang, Fady Gh Haddad, Issa F Khouri, Courtney D Di Nardo, Naveen Pemmaraju, William Wierda, Guillermo Garcia Manero, Partow Kebriaei, Rebecca Garris, Sanam Loghavi, Jeffrey Jorgensen, Monica Kwari, Susan O'Brien, Farhad Ravandi, Elias J Jabbour
Frontline combination of ponatinib and hyper-CVAD in Philadelphia chromosome-positive acute lymphoblastic leukemia: 80-months follow-up results. American journal of hematology 98 (3) (2023)
Jayastu Senapati, Muharrem Muftuoglu, Jo Ishizawa, Hussein A Abbas, Sanam Loghavi, Gautam Borthakur, Musa Ylimaz, Ghayas C Issa, Samuel I Dara, Mahesh Basyal, Li Li, Kiran Naqvi, Rasoul Pourebrahim, Elias J Jabbour, Steven M Kornblau, Nicholas James Short, Naveen Pemmaraju, Guillermo Garcia Manero, Farhad Ravandi, Joseph D Khoury, Naval G Daver, Hagop M Kantarjian, Michael Andreeff, Courtney D Di Nardo
A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis. Blood cancer journal 13 (1) (2023)
Timothy Anthony Yap, Naval G Daver, Mikhila Mahendra, Jixiang Zhang, Carlos Kamiya-Matsuoka, Funda Meric-Bernstam, Hagop M Kantarjian, Farhad Ravandi, Meghan E Collins, Maria Emilia Di Francesco, Ecaterina E Dumbrava, Siqing Fu, Sisi Gao, Jason P Gay, Sonal Gera, Jing Han, David S Hong, Elias J Jabbour, Zhenlin Ju, Daniel D Karp, Alessia Lodi, Jennifer R Molina, Natalia Baran, Aung Naing, Maro Ohanian, Shubham Pant, Naveen Pemmaraju, Prithviraj Bose, Sarina A Piha-Paul, Jordi Rodon, Carolina Salguero, Koiji Sasaki, Anand K Singh, Vivek Subbiah, Apostolia M Tsimberidou, Quanyun A Xu, Musa Ylimaz, Qi Zhang, Yuan Li, Christopher A Bristow, Meenakshi B Bhattacharjee, Stefano Tiziani, Timothy P Heffernan, Christopher P Vellano, Philip Jones, Cobi J Heijnen, Annemieke Kavelaars, Joseph R Marszalek, Marina Y Konopleva
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nature medicine 29 (1) (2023)
Andrew H Wei, Hartmut Döhner, Hamid Sayar, Farhad Ravandi, Pau Montesinos, Hervé Dombret, Dominik Selleslag, Kimmo Porkka, Jun-Ho Jang, Barry Skikne, C L Beach, Thomas Prebet, George Zhang, Alberto Risueño, Manuel Ugidos, Wendy L See, Daniel Menezes, Gail J Roboz
Long-term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: updated results from the randomized, placebo-controlled, phase 3 QUAZAR AML-001 trial. American journal of hematology (2023)
Guillermo Montalban Bravo, Elias Jabbour, Gautam Borthakur, Tapan Kadia, Farhad Ravandi, Kelly Sharon Chien, Naveen Pemmaraju, Danielle Hammond, Xiao Qin Dong, Xuelin Huang, Heather Schneider, Rosmy John, Rashmi Kanagal-Shamana, Sanam Loghavi, Hagop Kantarjian, Guillermo Garcia Manero
Phase 1/2 study of CPX-351 for patients with Int-2 or high risk International Prognostic Scoring System myelodysplastic syndromes and chronic myelomonocytic leukaemia after failure to hypomethylating agents. British journal of haematology (2023)
Maria Siddiqui, Sergej Konoplev, Ghayas C Issa, Hagop M Kantarjian, Naval G Daver, Farhad Ravandi, Tapan Mahendra Kadia, Guillin Tang, Sa A Wang, Beenu Thakral, L Jeffrey Medeiros, Olga Pozdnyakova, Sherry Pierce, Guillermo Montalban-Bravo, Kelly Sharon Chien, Danielle Hammond, Koiji Sasaki, Guillermo Garcia-Manero, Robert P Hasserjian
Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements. American journal of hematology 98 (4) (2023)
Nicholas James Short, Elias J Jabbour, Walid Macaron, Farhad Ravandi, Nitin Jain, Rashmi Kanagal-Shamana, Keyur P Patel, Sanam Loghavi, Fady Gh Haddad, Musa Ylimaz, Ghayas C Issa, Partow Kebriaei, Steven M Kornblau, Sarah Pelletier, Wilmer Flores, Jairo Matthews, Rebecca Garris, Hagop M Kantarjian
Ultrasensitive NGS MRD assessment in Ph+ ALL: Prognostic impact and correlation with RT-PCR for BCR::ABL1. American journal of hematology (2023)
Hagop M Kantarjian, Nicholas James Short, Nitin Jain, Koji Sasaki, Xuelin Huang, Fady Gh Haddad, Issa F Khouri, Courtney D Di Nardo, Naveen Pemmaraju, William Wierda, Guillermo Garcia Manero, Partow Kebriaei, Rebecca Garris, Sanam Loghavi, Jeffrey Jorgensen, Monica Kwari, Susan O'Brien, Farhad Ravandi, Elias J Jabbour
Frontline combination of ponatinib and hyper-CVAD in Philadelphia chromosome-positive acute lymphoblastic leukemia: 80-months follow-up results. American journal of hematology (2023)
Andrew H Wei, Hartmut Döhner, Hamid Sayar, Farhad Ravandi, Pau Montesinos, Hervé Dombret, Dominik Selleslag, Kimmo Porkka, Jun-Ho Jang, Barry Skikne, C L Beach, Thomas Prebet, George Zhang, Alberto Risueño, Manuel Ugidos, Wendy L See, Daniel Menezes, Gail J Roboz
Long-term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo-controlled, phase 3 QUAZAR AML-001 trial. American journal of hematology 98 (4) (2023)
Alexandre Bazinet, Hagop M Kantarjian, Naszrin Arani, Uday Popat, Alex Bataller, Koiji Sasaki, Courtney D Di Nardo, Naval G Daver, Musa Ylimaz, Hussein A Abbas, Nicholas James Short, Ghayas C Issa, Elias J Jabbour, Sherry A Pierce, Julianne Chen, Ricky Garcia, Marina Konopleva, Guillermo Garcia Manero, Amin Alousi, Elizabeth J Shpall, Richard E Champlin, Gautam Borthakur, Farhad Ravandi, Tapan Mahendra Kadia
Evolving trends and outcomes in older patients with acute myeloid leukemia including allogeneic stem cell transplantation. American journal of hematology (2023)
Jayastu Senapati, Warren C Fiskus, Naval G Daver, Nathaniel R Wilson, Farhad Ravandi, Guillermo Garcia Manero, Tapan Mahendra Kadia, Courtney D Di Nardo, Elias J Jabbour, Jan A Burger, Nicholas James Short, Yesid Alvarado, Nitin Jain, Lucia Masarova, Ghayas C Issa, Wei Qiao, Joseph D Khoury, Sherry Pierce, Darla Miller, Koiji Sasaki, Marina Y Konopleva, Kapil N Bhalla, Gautam Borthakur, Naveen Pemmaraju
Phase 1 Results of Bromodomain and Extraterminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Samuel Urrutia Argueta, Kelly Sharon Chien, Ziyi Li, Alex Bataller, Emmanuel Almanza, Koiji Sasaki, Guillermo Montalban Bravo, Nicholas James Short, Elias J Jabbour, Tapan Mahendra Kadia, Farhad Ravandi, Gautam Borthakur, Yesid Alvarado, Naval G Daver, Rashmi Kanagal-Shamana, Carlos Bueso-Ramos, Sherry A Pierce, Hagop M Kantarjian, Guillermo Garcia Manero
Performance of IPSS-M in patients with myelodysplastic syndrome after hypomethylating agent failure. American journal of hematology (2023)
Sai Prasad Desikan, Jayastu Senapati, Elias Jabbour, Tareq Abuasab, Nicholas Short, Guillin Tang, Sa Wang, Partow Kebriaei, Tapan Mahendra Kadia, Gautam Borthakur, Farhad Ravandi, Kathryn Roberts, Charles Mullighan, Marina Y Konopleva, Hagop M Kantarjian, Nitin Jain
Outcomes of adult patients with relapsed/refractory CRLF2 rearranged B-cell acute lymphoblastic leukemia. American journal of hematology (2023)
Wei-Ying Jen, Koiji Sasaki, Caitlin R Rausch, Courtney D Di Nardo, Tapan Mahendra Kadia, Musa Ylimaz, Gautam Borthakur, Yesid Alvarado, David McCue, Deborah Mccue, Hagop M Kantarjian, Farhad Ravandi
Acute kidney injury in acute promyelocytic leukemia: a possible adverse effect of high dose arsenic trioxide in obese patients. Leukemia & lymphoma (2023)
Maria Siddiqui, Sergej Konoplev, Ghayas C Issa, Hagop M Kantarjian, Naval G Daver, Farhad Ravandi, Tapan Mahendra Kadia, Guillin Tang, Sa A Wang, Beenu Thakral, L Jeffrey Medeiros, Olga Pozdnyakova, Sherry Pierce, Guillermo Montalban-Bravo, Kelly Sharon Chien, Danielle Hammond, Koiji Sasaki, Guillermo Garcia-Manero, Robert P Hasserjian
Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements. American journal of hematology 98 (4) (2023)
Jayastu Senapati, Muharrem Muftuoglu, Jo Ishizawa, Hussein A Abbas, Sanam Loghavi, Gautam Borthakur, Musa Ylimaz, Ghayas C Issa, Samuel I Dara, Mahesh Basyal, Li Li, Kiran Naqvi, Rasoul Pourebrahim, Elias J Jabbour, Steven M Kornblau, Nicholas James Short, Naveen Pemmaraju, Guillermo Garcia Manero, Farhad Ravandi, Joseph D Khoury, Naval G Daver, Hagop M Kantarjian, Michael Andreeff, Courtney D Di Nardo
A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis. Blood cancer journal 13 (1) (2023)
Maria Siddiqui, Sergej Konoplev, Ghayas C Issa, Hagop M Kantarjian, Naval G Daver, Farhad Ravandi, Tapan Mahendra Kadia, Guillin Tang, Sa A Wang, Beenu Thakral, L Jefferey Medeiros, Olga Pozdnyakova, Sherry Pierce, Guillermo Montalban Bravo, Kelly Sharon Chien, Danielle Hammond, Koiji Sasaki, Guillermo Garcia Manero, Robert P Hasserjian
Biologic Features and Clinical Outcomes in Newly Diagnosed Myelodysplastic Syndrome with KMT2A rearrangements. American journal of hematology (2023)
Nicholas James Short, Daniel Nguyen, Farhad Ravandi
Treatment of older adults with FLT3-mutated AML: Emerging paradigms and the role of frontline FLT3 inhibitors. Blood cancer journal 13 (1) (2023)
Andrew H Wei, Hartmut Döhner, Hamid Sayar, Farhad Ravandi, Pau Montesinos, Hervé Dombret, Dominik Selleslag, Kimmo Porkka, Jun-Ho Jang, Barry Skikne, C L Beach, Thomas Prebet, George Zhang, Alberto Risueño, Manuel Ugidos, Wendy L See, Daniel Menezes, Gail J Roboz
Long-term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo-controlled, phase 3 QUAZAR AML-001 trial. American journal of hematology 98 (4) (2023)
Hagop M Kantarjian, Nicholas James Short, Nitin Jain, Koji Sasaki, Xuelin Huang, Fady Gh Haddad, Issa F Khouri, Courtney D Di Nardo, Naveen Pemmaraju, William Wierda, Guillermo Garcia Manero, Partow Kebriaei, Rebecca Garris, Sanam Loghavi, Jeffrey Jorgensen, Monica Kwari, Susan O'Brien, Farhad Ravandi, Elias J Jabbour
Frontline combination of ponatinib and hyper-CVAD in Philadelphia chromosome-positive acute lymphoblastic leukemia: 80-months follow-up results. American journal of hematology 98 (3) (2023)
Sai Prasad Desikan, Jayastu Senapati, Elias J Jabbour, Tareq Abuasab, Nicholas James Short, Guillin Tang, Sa Wang, Partow Kebriaei, Tapan Mahendra Kadia, Gautam Borthakur, Farhad Ravandi, Kathryn Roberts, Charles G Mullighan, Marina Y Konopleva, Hagop M Kantarjian, Nitin Jain
Outcomes of adult patients with relapsed/refractory CRLF2 rearranged B-cell acute lymphoblastic leukemia. American journal of hematology (2023)
Andrew H Wei, Hartmut Döhner, Hamid Sayar, Farhad Ravandi, Pau Montesinos, Hervé Dombret, Dominik Selleslag, Kimmo Porkka, Jun-Ho Jang, Barry Skikne, C L Beach, Thomas Prebet, George Zhang, Alberto Risueño, Manuel Ugidos, Wendy L See, Daniel Menezes, Gail J Roboz
Long-term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: updated results from the randomized, placebo-controlled, phase 3 QUAZAR AML-001 trial. American journal of hematology (2023)
Andrew H Wei, Hartmut Döhner, Hamid Sayar, Farhad Ravandi, Pau Montesinos, Hervé Dombret, Dominik Selleslag, Kimmo Porkka, Jun-Ho Jang, Barry Skikne, C L Beach, Thomas Prebet, George Zhang, Alberto Risueño, Manuel Ugidos, Wendy L See, Daniel Menezes, Gail J Roboz
Long-term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo-controlled, phase 3 QUAZAR AML-001 trial. American journal of hematology 98 (4) (2023)
Timothy Anthony Yap, Naval G Daver, Mikhila Mahendra, Jixiang Zhang, Carlos Kamiya-Matsuoka, Funda Meric-Bernstam, Hagop M Kantarjian, Farhad Ravandi, Meghan E Collins, Maria Emilia Di Francesco, Ecaterina E Dumbrava, Siqing Fu, Sisi Gao, Jason P Gay, Sonal Gera, Jing Han, David S Hong, Elias J Jabbour, Zhenlin Ju, Daniel D Karp, Alessia Lodi, Jennifer R Molina, Natalia Baran, Aung Naing, Maro Ohanian, Shubham Pant, Naveen Pemmaraju, Prithviraj Bose, Sarina A Piha-Paul, Jordi Rodon, Carolina Salguero, Koiji Sasaki, Anand K Singh, Vivek Subbiah, Apostolia M Tsimberidou, Quanyun A Xu, Musa Ylimaz, Qi Zhang, Yuan Li, Christopher A Bristow, Meenakshi B Bhattacharjee, Stefano Tiziani, Timothy P Heffernan, Christopher P Vellano, Philip Jones, Cobi J Heijnen, Annemieke Kavelaars, Joseph R Marszalek, Marina Y Konopleva
Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nature medicine (2023)
Alex Bataller, Sanam Loghavi, Yoheved Gerstein, Alexandre Bazinet, Koiji Sasaki, Kelly Sharon Chien, Danielle Hammond, Guillermo Montalban Bravo, Gautam Borthakur, Nicholas James Short, Ghayas C Issa, Tapan Mahendra Kadia, Naval G Daver, Guillin Tang, Andres Quesada, Keyur P Patel, Farhad Ravandi, Warren Fiskus, Cristopher P Mill, Hagop M Kantarjian, Kapil N Bhalla, Guillermo Garcia Manero, Betul Oran, Courtney D Di Nardo
Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants. American journal of hematology (2023)
Hagop M Kantarjian, Nicholas James Short, Nitin Jain, Koji Sasaki, Xuelin Huang, Fady Gh Haddad, Issa F Khouri, Courtney D Di Nardo, Naveen Pemmaraju, William Wierda, Guillermo Garcia Manero, Partow Kebriaei, Rebecca Garris, Sanam Loghavi, Jeffrey Jorgensen, Monica Kwari, Susan O'Brien, Farhad Ravandi, Elias J Jabbour
Frontline combination of ponatinib and hyper-CVAD in Philadelphia chromosome-positive acute lymphoblastic leukemia: 80-months follow-up results. American journal of hematology 98 (3) (2023)
Jayastu Senapati, Elias J Jabbour, Marina Y Konopleva, Nicholas James Short, Guillin Tang, Naval G Daver, Partow Kebriaei, Tapan Mahendra Kadia, Naveen Pemmaraju, Koichi Takahashi, Courtney D Di Nardo, Koiji Sasaki, Gautam Borthakur, Beenu Thakral, Rashmi Kanagal-Shamana, Keyur Pravinchandra Patel, Farhad Ravandi, Kathryn G Roberts, Charles G Mullighan, Hagop M Kantarjian, Nitin Jain
Philadelphia-Like Genetic Rearrangements in Adults With B-Cell ALL: Refractoriness to Chemotherapy and Response to Tyrosine Kinase Inhibitor in ABL Class Rearrangements. JCO precision oncology 7 (2023)
Hussein A Abbas, Edward Ayoub, Hanxiao Sun, Rashmi Kanagal-Shamana, Nicholas James Short, Ghayas C Issa, Musa Ylimaz, Sherry Pierce, Daniel Rivera, Brent Cham, Shane Wing, Ziyi Li, Danielle Hammond, Elias Jabbour, Gautam Borthakur, Guillermo Garcia-Manero, Michael Andreeff, Naval G Daver, Tapan Kadia, Marina Konopleva, Courtney D Di Nardo, Farhad Ravandi
Clinical and molecular profiling of AML patients with chromosome 7 or 7q deletions in the context of TP53 alterations and venetoclax treatment. Leukemia & lymphoma (2022)
Jayastu Senapati, Tareq Abuasab, Fady Gh Haddad, Farhad Ravandi, Tapan Mahendra Kadia, Courtney D Di Nardo, Naval G Daver, Naveen Pemmaraju, Yesid Alvarado, Mark A Brandt, Hagop M Kantarjian, Gautam Borthakur
Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens. American journal of hematology 98 (3) (2022)
Oren Pasvolsky, Rima M Saliba, Celina Ledesma, Uday R Popat, Amin Alousi, Amanda L Olson, Betul Oran, Chitra Hosing, Qaiser Bashir, Muzaffar H Qazilbash, Nicholas James Short, Farhad Ravandi, Richard Champlin, Elizabeth J Shpall, Partow Kebriaei
Prognostic significance of measurable residual disease in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation in second or later complete remission. American journal of hematology 98 (2) (2022)
Jayastu Senapati, Mahran Shoukier, Guillermo Garcia Manero, Xuemei Wang, Keyur Patel, Tapan Mahendra Kadia, Farhad Ravandi, Naveen Pemmaraju, Maro Ohanian DO, Naval G Daver, Courtney D Di Nardo, Yesid Alvarado, Jeffrey Aldrich, Gautam Borthakur
Activity of decitabine as maintenance therapy in core binding factor acute myeloid leukemia. American journal of hematology 97 (5) (2022)
Siba El Hussein, Courtney D DiNardo, Koichi Takahashi, Joseph D Khoury, Hong Fang, Ken Furudate, Kirill A Lyapichev, Sofia Garces, Rashmi Kanagal-Shamana, Chi Young Ok, Keyur Pravinchandra Patel, Mark J Routbort, Farhad Ravandi, L Jeffrey Medeiros, Sa A Wang, Sanam Loghavi
Acquired WT1 mutations contribute to relapse of NPM1-mutated acute myeloid leukemia following allogeneic hematopoietic stem cell transplant. Bone marrow transplantation 57 (3) (2022)
Gautam Borthakur, Farhad Ravandi, Keyur Patel, Xuemei Wang, Tapan Mahendra Kadia, Courtney D Di Nardo, Guillermo Garcia Manero, Naveen Pemmaraju, Elias J Jabbour, Koichi Takahashi, Maro Ohanian DO, Naval G Daver, Yesid Alvarado, Mark Brandt, Sherry Pierce, Hagop M Kantarjian
Retrospective comparison of survival and responses to Fludarabine, Cytarabine, GCSF (FLAG) in combination with gemtuzumab ozogamicin (GO) or Idarubicin (IDA) in patients with newly diagnosed core binding factor (CBF) acute myelogenous leukemia: MD Anderson experience in 174 patients. American journal of hematology 97 (11) (2022)
Jayastu Senapati, Tareq Abuasab, Fady Gh Haddad, Farhad Ravandi, Tapan Mahendra Kadia, Courtney D Di Nardo, Naval G Daver, Naveen Pemmaraju, Yesid Alvarado, Mark A Brandt, Hagop M Kantarjian, Gautam Borthakur
Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens. American journal of hematology (2022)
Sangeetha Venugopal, Courtney D Di Nardo, Sanam Loghavi, Wei Qiao, Farhad Ravandi, Marina Y Konopleva, Tapan Mahendra Kadia, Kapil N Bhalla, Elias J Jabbour, Ghayas C Issa, Walid Macaron, Naval G Daver, Gautam Borthakur, Guillermo Montalban Bravo, Musa Ylimaz, Keyur P Patel, Rashmi Kanagal-Shamana, Kelly Sharon Chien, Abhishek Maiti, Hagop M Kantarjian, Nicholas James Short
Differential prognostic impact of RUNX1 mutations according to frontline therapy in patients with acute myeloid leukemia. American journal of hematology 97 (12) (2022)
Daniel Rivera, Kunhwa Kim, Rashmi Kanagal-Shamana, Gautam Borthakur, Guillermo Montalban Bravo, Naval G Daver, Courtney D Di Nardo, Nicholas James Short, Musa Ylimaz, Naveen Pemmaraju, Koichi Takahashi, Elias J Jabbour, Sherry Pierce, Marina Y Konopleva, Kapil N Bhalla, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Implications of RAS mutational status in subsets of patients with newly diagnosed acute myeloid leukemia across therapy subtypes. American journal of hematology 97 (12) (2022)
Kayleigh R Marx, Caitlin R Rausch, Alexandra R Lovell, Nicholas James Short, Shilpa Paul, Nitin Jain, Jenessa Lee, J Michael Savoy, Farhad Ravandi, Elias J Jabbour
Incidence of adverse effects in patients receiving ponatinib with concomitant azole antifungals. Leukemia & lymphoma (2022)
Farhad Ravandi, Robert J Kreitman, Enrico Tiacci, Leslie Andritsos, Versha Banerji, Jacqueline C Barrientos, Seema A Bhat, James S Blachly, Alessandro Broccoli, Timothy Call, Dai Chihara, Claire Dearden, Judit Demeter, Sascha Dietrich, Monica Else, Narendranath Epperla, Brunangelo Falini, Francesco Forconi, Douglas E Gladstone, Alessandro Gozzetti, Sunil Iyengar, James B Johnston, Jeffrey L Jorgensen, Gunnar Juliusson, Francesco Lauria, Gerard Lozanski, Sameer A Parikh, Jae H Park, Aaron Polliack, Graeme Quest, Tadeusz Robak, Kerry A Rogers, Alan Saven, John Francis Seymour, Tamar Tadmor, Martin S Tallman, Constantine S Tam, Phillip A Thompson, Xavier Troussard, Clive S Zent, Thorsten Zenz, Pier Luigi Luigi Zinzani, Bernhard Woermann, Kanti R Rai, Michael Grever
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia. Blood cancer journal 12 (12) (2022)
Nicholas James Short, Walid Macaron, Tapan Mahendra Kadia, Courtney D Di Nardo, Ghayas C Issa, Naval G Daver, Sa Wang, Jeff Jorgensen, Daniel Nguyen, Aram Bidikian, Keyur P Patel, Sanam Loghavi, Marina Y Konopleva, Musa Ylimaz, Elias J Jabbour, Abhishek Maiti, Hussein A Abbas, Elizabeth Shpall, Uday Popat, Gheath Al-Atrash, Sherry Pierce, Hagop M Kantarjian, Farhad Ravandi
Clinical outcomes and impact of therapeutic intervention in patients with acute myeloid leukemia who experience measurable residual disease (MRD) recurrence following MRD-negative remission. American journal of hematology 97 (11) (2022)
Leslie A Andritsos, Mirela Anghelina, Jasmine Neal, James S Blachly, Puneet Mathur, Omkar Lele, Claire Dearden, Sunil Iyengar, Matthew Cross, Clive S Zent, Kerry A Rogers, Narendranath Epperla, Gerard Lozanski, Christopher C Oakes, Eric Kraut, Amy S Ruppert, Qiuhong Zhao, Seema A Bhat, Francesco Forconi, Versha Banerji, Sasanka Handunnetti, Constantine S Tam, John F Seymour, Monica Else, Robert J Kreitman, Alan Saven, Timothy Call, Sameer A Parikh, Farhad Ravandi, James B Johnston, Enrico Tiacci, Xavier Troussard, Martin S Tallman, Sascha Dietrich, Tamar Tadmor, Alessandro Gozzetti, Pier Luigi Zinzani, Tadeusz Robak, Graeme Quest, Judit Demeter, Kanti Rai, Soledad A Fernandez, Michael Grever
Development of a distributed international patient data registry for hairy cell leukemia. Leukemia & lymphoma (2022)
Tapan Mahendra Kadia, Patrick K Reville, Xuemei Wang, Caitlin R Rausch, Gautam Borthakur, Naveen Pemmaraju, Naval G Daver, Courtney D DiNardo, Koiji Sasaki, Ghayas C Issa, Maro Ohanian DO, Guillermo Montalban-Bravo, Nicholas James Short, Nitin Jain, Alessandra Ferrajoli, Kapil N Bhalla, Elias J Jabbour, Koichi Takahashi, Rashmi Malla, Kelly Quagliato, Rashmi Kanagal-Shamana, Sairah A Ahmed, Michael Andreeff, Guillermo Garcia Manero, Marina Y Konopleva, Farhad Ravandi, Hagop M Kantarjian
Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (33) (2022)
Elias J Jabbour, Nicholas James Short, Nitin Jain, Nadya J Jammal, Jeffrey Jorgensen, Sa Wang, Xuemei Wang, Maro Ohanian DO, Yesid Alvarado, Tapan Mahendra Kadia, Koiji Sasaki, Rebecca Garris, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian
Blinatumomab is associated with favorable outcomes in patients with B-cell lineage acute lymphoblastic leukemia and positive measurable residual disease at a threshold of 10 -4 and higher. American journal of hematology 97 (9) (2022)
Koiji Sasaki, Farhad Ravandi, Tapan Mahendra Kadia, Courtney D Di Nardo, Gautam Borthakur, Nicholas James Short, Nitin Jain, Naval G Daver, Elias J Jabbour, Guillermo Garcia Manero, Joseph D Khoury, Sergej Konoplev, Sanam Loghavi, Keyur Patel, Guillermo Montalban Bravo, Lucia Masarova, Marina Y Konopleva, Hagop Kantarjian
Prediction of survival with intensive chemotherapy in acute myeloid leukemia. American journal of hematology 97 (7) (2022)
Jayastu Senapati, Tareq Abuasab, Fady Gh Haddad, Farhad Ravandi, Tapan Mahendra Kadia, Courtney D Di Nardo, Naval G Daver, Naveen Pemmaraju, Yesid Alvarado, Mark A Brandt, Hagop M Kantarjian, Gautam Borthakur
Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens. American journal of hematology 98 (3) (2022)
Shilpa Paul, Hagop Kantarjian, Koiji Sasaki, Kayleigh Marx, Nitin Jain, J Michael Savoy, Adam J DiPippo, Nadya Jammal, Guillermo Montalban Bravo, Tapan Mahendra Kadia, Guillermo Garcia Manero, Nicholas James Short, Farhad Ravandi, Elias J Jabbour
Intrathecal prophylaxis with 12 versus 8 administrations reduces the incidence of central nervous system relapse in patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia. American journal of hematology (2022)
Aram Bidikian, Hagop M Kantarjian, Elias J Jabbour, Nicholas James Short, Keyur Pravinchandra Patel, Farhad Ravandi, Koiji Sasaki, Ghayas C Issa
Prognostic impact of ASXL1 mutations in chronic phase chronic myeloid leukemia. Blood cancer journal 12 (10) (2022)
Sangeetha Venugopal, Koichi Takahashi, Naval G Daver, Abhishek Maiti, Gautam Borthakur, Sanam Loghavi, Nicholas James Short, Maro Ohanian, Lucia Masarova, Ghayas C Issa, Xuemei Wang, Bueso-Ramos Carlos, Musa Ylimaz, Tapan Mahendra Kadia, Michael Andreeff, Farhad Ravandi, Marina Y Konopleva, Hagop M Kantarjian, Courtney D Di Nardo
Efficacy and safety of enasidenib and azacitidine combination in patients with IDH2 mutated acute myeloid leukemia and not eligible for intensive chemotherapy. Blood cancer journal 12 (1) (2022)
Farhad Ravandi, Robert J Kreitman, Enrico Tiacci, Leslie Andritsos, Versha Banerji, Jacqueline C Barrientos, Seema A Bhat, James S Blachly, Alessandro Broccoli, Timothy Call, Dai Chihara, Claire Dearden, Judit Demeter, Sascha Dietrich, Monica Else, Narendranath Epperla, Brunangelo Falini, Francesco Forconi, Douglas E Gladstone, Alessandro Gozzetti, Sunil Iyengar, James B Johnston, Jeffrey L Jorgensen, Gunnar Juliusson, Francesco Lauria, Gerard Lozanski, Sameer A Parikh, Jae H Park, Aaron Polliack, Graeme Quest, Tadeusz Robak, Kerry A Rogers, Alan Saven, John Francis Seymour, Tamar Tadmor, Martin S Tallman, Constantine S Tam, Phillip A Thompson, Xavier Troussard, Clive S Zent, Thorsten Zenz, Pier Luigi Luigi Zinzani, Bernhard Woermann, Kanti R Rai, Michael Grever
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia. Blood cancer journal 12 (12) (2022)
Nicholas James Short, Walid Macaron, Marina Y Konopleva, Farhad Ravandi, Nitin Jain, Ghayas C Issa, Tapan Mahendra Kadia, Koiji Sasaki, Partow Kebriaei, Musa Ylimaz, Philip A Thompson, Koichi Takahashi, Hussein A Abbas, William G Wierda, Rebecca Garris, Hagop M Kantarjian, Elias J Jabbour
Dismal outcomes of patients with relapsed/refractory Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia after failure of both inotuzumab ozogamicin and blinatumomab. American journal of hematology 97 (6) (2022)
Curtis A Lachowiez, Patrick K Reville, Hagop M Kantarjian, Elias J Jabbour, Gautam Borthakur, Naval G Daver, Ghayas C Issa, Ken Furudate, Tomoyuki Tanaka, Sherry Pierce, Guillin Tang, Keyur P Patel, Jeffrey Medeiros, Hussein A Abbas, Fady Gh Haddad, Daniel Hammond, Nicholas James Short, Abhishek Maiti, Musa Ylimaz, Koiji Sasaki, Koichi Takahashi, Naveen Pemmaraju, Marina Y Konopleva, Guillermo Garcia Manero, Farhad Ravandi, Tapan Mahendra Kadia, Sanam Loghavi, Courtney D Di Nardo
Contemporary outcomes in IDH-mutated acute myeloid leukemia: The impact of co-occurring NPM1 mutations and venetoclax-based treatment. American journal of hematology 97 (11) (2022)
Kumiko Chino, Hagop M Kantarjian, Nicholas James Short, Feng Wang, Ken Furudate, Hidetaka Uryu, Rebecca Garris, Nitin Jain, Koiji Sasaki, Farhad Ravandi, Marina Y Konopleva, Guillermo Garcia Manero, Latasha Little, Curtis Gumbs, Li Zhao, P Andrew Futreal, Koichi Takahashi, Elias J Jabbour
Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinib. Leukemia 36 (5) (2022)
Farhad Ravandi, Robert J Kreitman, Enrico Tiacci, Leslie Andritsos, Versha Banerji, Jacqueline C Barrientos, Seema A Bhat, James S Blachly, Alessandro Broccoli, Timothy Call, Dai Chihara, Claire Dearden, Judit Demeter, Sascha Dietrich, Monica Else, Narendranath Epperla, Brunangelo Falini, Francesco Forconi, Douglas E Gladstone, Alessandro Gozzetti, Sunil Iyengar, James B Johnston, Jeffrey L Jorgensen, Gunnar Juliusson, Francesco Lauria, Gerard Lozanski, Sameer A Parikh, Jae H Park, Aaron Polliack, Graeme Quest, Tadeusz Robak, Kerry A Rogers, Alan Saven, John Francis Seymour, Tamar Tadmor, Martin S Tallman, Constantine S Tam, Phillip A Thompson, Xavier Troussard, Clive S Zent, Thorsten Zenz, Pier Luigi Luigi Zinzani, Bernhard Woermann, Kanti R Rai, Michael Grever
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia. Blood cancer journal 12 (12) (2022)
Oren Pasvolsky, Rima M Saliba, Celina Ledesma, Uday R Popat, Amin Alousi, Amanda L Olson, Betul Oran, Chitra Hosing, Qaiser Bashir, Muzaffar H Qazilbash, Nicholas James Short, Farhad Ravandi, Richard Champlin, Elizabeth J Shpall, Partow Kebriaei
Prognostic significance of measurable residual disease in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation in second or later complete remission. American journal of hematology 98 (2) (2022)
Farhad Ravandi, Robert J Kreitman, Enrico Tiacci, Leslie Andritsos, Versha Banerji, Jacqueline C Barrientos, Seema A Bhat, James S Blachly, Alessandro Broccoli, Timothy Call, Dai Chihara, Claire Dearden, Judit Demeter, Sascha Dietrich, Monica Else, Narendranath Epperla, Brunangelo Falini, Francesco Forconi, Douglas E Gladstone, Alessandro Gozzetti, Sunil Iyengar, James B Johnston, Jeffrey L Jorgensen, Gunnar Juliusson, Francesco Lauria, Gerard Lozanski, Sameer A Parikh, Jae H Park, Aaron Polliack, Graeme Quest, Tadeusz Robak, Kerry A Rogers, Alan Saven, John Francis Seymour, Tamar Tadmor, Martin S Tallman, Constantine S Tam, Phillip A Thompson, Xavier Troussard, Clive S Zent, Thorsten Zenz, Pier Luigi Luigi Zinzani, Bernhard Woermann, Kanti R Rai, Michael Grever
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia. Blood cancer journal 12 (12) (2022)
Kunhwa Kim, Marina Y Konopleva, Courtney D Di Nardo, Gautam Borthakur, Sanam Loghavi, Guillin Tang, Naval G Daver, Naveen Pemmaraju, Elias J Jabbour, Caitlin R Rausch, Musa Ylimaz, Koiji Sasaki, Nicholas James Short, Nitin Jain, Mark Brandt, Sherry Pierce, Guillermo Garcia Manero, Farhad Ravandi, Hagop Kantarjian, Tapan Mahendra Kadia
Urgent cytoreduction for newly diagnosed acute myeloid leukemia patients allows acquisition of pretreatment genomic data and enrollment on investigational clinical trials. American journal of hematology 97 (7) (2022)
Musa Ylimaz, Hagop M Kantarjian, Nicholas James Short, Patrick K Reville, Marina Y Konopleva, Tapan Mahendra Kadia, Courtney D Di Nardo, Gautam Borthakur, Naveen Pemmaraju, Abhishek Maiti, Elias J Jabbour, Nitin Jain, Ghayas C Issa, Koichi Takahashi, Koiji Sasaki, Maro Ohanian, Sherry Pierce, Guillin Tang, Sanam Loghavi, Keyur Pravinchandra Patel, Sa A Wang, Guillermo Garcia Manero, Michael Andreeff, Farhad Ravandi, Naval G Daver
Hypomethylating agent and venetoclax with FLT3 inhibitor "triplet" therapy in older/unfit patients with FLT3 mutated AML. Blood cancer journal 12 (5) (2022)
Oren Pasvolsky, Rima M Saliba, Celina Ledesma, Uday R Popat, Amin Alousi, Amanda L Olson, Betul Oran, Chitra Hosing, Qaiser Bashir, Muzaffar H Qazilbash, Nicholas James Short, Farhad Ravandi, Richard Champlin, Elizabeth J Shpall, Partow Kebriaei
Prognostic significance of measurable residual disease in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation in second or later complete remission. American journal of hematology 98 (2) (2022)
Jayastu Senapati, Tareq Abuasab, Fady Gh Haddad, Farhad Ravandi, Tapan Mahendra Kadia, Courtney D Di Nardo, Naval G Daver, Naveen Pemmaraju, Yesid Alvarado, Mark A Brandt, Hagop M Kantarjian, Gautam Borthakur
Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens. American journal of hematology 98 (3) (2022)
Sai Prasad Desikan, Naval G Daver, Courtney DiNardo, Tapan Mahendra Kadia, Marina Y Konopleva, Farhad Ravandi
Resistance to targeted therapies: delving into FLT3 and IDH. Blood cancer journal 12 (6) (2022)
Courtney D Di Nardo, Curtis A Lachowiez, Koichi Takahashi, Sanam Loghavi, Tapan Mahendra Kadia, Naval G Daver, Lianchun Xiao, Maria Adeoti, Nicholas James Short, Koji Sasaki, Sa A Wang, Gautam Borthakur, Ghayas Issa, Abhishek Maiti, Yesid Alvarado, Naveen Pemmaraju, Guillermo Montalban Bravo, Lucia Masarova, Musa Ylimaz, Nitin Jain, Michael Andreeff, Guillermo Garcia Manero, Steven Kornblau, Farhad Ravandi, Elias J Jabbour, Marina Y Konopleva, Hagop M Kantarjian
Venetoclax combined with FLAG-IDA induction and consolidation in newly diagnosed acute myeloid leukemia. American journal of hematology 97 (8) (2022)
Oren Pasvolsky, Rima M Saliba, Celina Ledesma, Uday R Popat, Amin Alousi, Amanda L Olson, Betul Oran, Chitra Hosing, Qaiser Bashir, Muzaffar H Qazilbash, Nicholas James Short, Farhad Ravandi, Richard Champlin, Elizabeth J Shpall, Partow Kebriaei
Prognostic significance of measurable residual disease in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation in second or later complete remission. American journal of hematology (2022)
Ayalew Tefferi, Naseema Gangat, Aref Al-Kali, Hassan Alkhateeb, Mithun Vinod Shah, Mirinal S Patnaik, Michelle A Elliott, William J Hogan, Mark R Litzow, Christopher C Hook, Abhishek A Mangaonkar, David Viswanatha, Dong Chen, Animesh D Pardanani, Rhett P Ketterling, Courtney D Di Nardo, Tapan Mahendra Kadia, Farhad Ravandi, Koji Sasaki, Kebede H Begna
A dynamic 3-factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapy. American journal of hematology 97 (9) (2022)
Jayastu Senapati, Tareq Abuasab, Fady Gh Haddad, Farhad Ravandi, Tapan Mahendra Kadia, Courtney D Di Nardo, Naval G Daver, Naveen Pemmaraju, Yesid Alvarado, Mark A Brandt, Hagop M Kantarjian, Gautam Borthakur
Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G-CSF based regimens. American journal of hematology 98 (3) (2022)
Farhad Ravandi, Robert J Kreitman, Enrico Tiacci, Leslie Andritsos, Versha Banerji, Jacqueline C Barrientos, Seema A Bhat, James S Blachly, Alessandro Broccoli, Timothy Call, Dai Chihara, Claire Dearden, Judit Demeter, Sascha Dietrich, Monica Else, Narendranath Epperla, Brunangelo Falini, Francesco Forconi, Douglas E Gladstone, Alessandro Gozzetti, Sunil Iyengar, James B Johnston, Jeffrey L Jorgensen, Gunnar Juliusson, Francesco Lauria, Gerard Lozanski, Sameer A Parikh, Jae H Park, Aaron Polliack, Graeme Quest, Tadeusz Robak, Kerry A Rogers, Alan Saven, John Francis Seymour, Tamar Tadmor, Martin S Tallman, Constantine S Tam, Phillip A Thompson, Xavier Troussard, Clive S Zent, Thorsten Zenz, Pier Luigi Luigi Zinzani, Bernhard Woermann, Kanti R Rai, Michael Grever
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia. Blood cancer journal 12 (12) (2022)
Nicholas James Short, Chenqi Fu, Donald A Berry, Roland Bruno Walter, Sylvie D Freeman, Christopher S Hourigan, Xuelin Huang, Graciela Nogueras Gonzalez, Hyunsoo Hwang, Xinyue Qi, Hagop M Kantarjian, Shouhao Zhou, Farhad Ravandi
Association of hematologic response and assay sensitivity on the prognostic impact of measurable residual disease in acute myeloid leukemia: a systematic review and meta-analysis. Leukemia 36 (12) (2022)
Patrick K Reville, Koiji Sasaki, Hagop M Kantarjian, Naval G Daver, Musa Ylimaz, Courtney D Di Nardo, Nicholas James Short, Gautam Borthakur, Naveen Pemmaraju, Rohtesh S Mehta, Sherry Pierce, Sergej N Konoplev, Joseph D Khoury, Guillermo Garcia Manero, Marina Y Konopleva, Elias Jabbour, Farhad Ravandi, Tapan Mahendra Kadia
Improved outcomes among newly diagnosed patients with FMS-like tyrosine kinase 3 internal tandem duplication mutated acute myeloid leukemia treated with contemporary therapy: Revisiting the European LeukemiaNet adverse risk classification. American journal of hematology 97 (3) (2022)
Fady Gh Haddad, Koiji Sasaki, Ghayas C Issa, Guillermo Garcia Manero, Farhad Ravandi, Tapan Mahendra Kadia, Jorge E Cortes, Marina Y Konopleva, Naveen Pemmaraju, Yesid Alvarado, Musa Ylimaz, Gautam Borthakur, Courtney D Di Nardo, Nitin Jain, Naval G Daver, Nicholas James Short, Elias J Jabbour, Hagop Kantarjian
Treatment-free remission in patients with chronic myeloid leukemia following the discontinuation of tyrosine kinase inhibitors. American journal of hematology 97 (7) (2022)
Ghayas C Issa, Jabra Zarka, Koji Sasaki, Wei Qiao, Daewoo Pak, Jing Ning, Nicholas James Short, Fadi Haddad, Zhenya Tang, Keyur Pravinchandra Patel, Branko Cuglievan, Naval G Daver, Courtney D Di Nardo, Elias J Jabbour, Tapan Mahendra Kadia, Gautam Borthakur, Guillermo Garcia Manero, Marina Y Konopleva, Michael Andreeff, Hagop M Kantarjian, Farhad Ravandi
Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements. Blood cancer journal 11 (9) (2021)
Nitin Jain, Abhishek Maiti, Farhad Ravandi, Marina Y Konopleva, Naval G Daver, Tapan Mahendra Kadia, Naveen Pemmaraju, Nicholas James Short, Partow Kebriaei, Jing Ning, Jorge E Cortes, Elias J Jabbour, Hagop Kantarjian
Inotuzumab ozogamicin with bosutinib for relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia or lymphoid blast phase of chronic myeloid leukemia. American journal of hematology 96 (8) (2021)
Hagop M Kantarjian, Kebede H Begna, Jessica K Altman, Stuart L Goldberg, Mikkael A Sekeres, Stephen A Strickland, Martha L Arellano, David F Claxton, Maria R Baer, Marc Gautier, Ellin Berman, Karen Seiter, Scott R Solomon, Gary J Schiller, Selina M Luger, Aleksandra Butrym, Gianluca Gaidano, Xavier G Thomas, Pau Montesinos, David A Rizzieri, Donald P Quick, Parameswaran Venugopal, Rakesh Gaur, Lori J Maness, Tapan Mahendra Kadia, Farhad Ravandi, Marc E Buyse, Judy H Chiao
Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS). Cancer 127 (23) (2021)
Farhad Ravandi, Gail J Roboz, Andrew H Wei, Hartmut Döhner, Christopher Pocock, Dominik Selleslag, Pau Montesinos, Hamid Sayar, Maurizio Musso, Angela Figuera-Alvarez, Hana Safah, William Tse, Sang Kyun Sohn, Devendra Hiwase, Timothy Chevassut, Francesca Pierdomenico, Ignazia La Torre, Barry Skikne, Rochelle Bailey, Jianhua Zhong, C L Beach, Herve Dombret
Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial. Journal of hematology & oncology 14 (1) (2021)
Musa Ylimaz, Hagop M Kantarjian, Farhad Ravandi
Acute promyelocytic leukemia current treatment algorithms. Blood cancer journal 11 (6) (2021)
Yasmin Alwash, Joseph D Khoury, Mehrnoosh Tashakori, Rashmi Kanagal-Shamana, Naval G Daver, Farhad Ravandi, Tapan Mahendra Kadia, Marina Y Konopleva, Courtney D Di Nardo, Ghayas C Issa, Sanam Loghavi, Koichi Takahashi, Elias J Jabbour, Veronica Guerra, Steven Kornblau, Hagop Kantarjian, Nicholas James Short
Development of TP53 mutations over the course of therapy for acute myeloid leukemia. American journal of hematology 96 (11) (2021)
Koiji Sasaki, Tapan Mahendra Kadia, Kebede H Begna, Courtney D Di Nardo, Gautam Borthakur, Nicholas James Short, Nitin Jain, Naval G Daver, Elias J Jabbour, Guillermo Garcia Manero, Guillermo Montalban Bravo, Lucia Masarova, Sherry Pierce, Marina Y Konopleva, Farhad Ravandi, Ayalew Tefferi, Hagop Kantarjian
Prediction of early (4-week) mortality in acute myeloid leukemia with intensive chemotherapy. American journal of hematology (2021)
Guillermo Garcia Manero, Sherry Pierce, Farhad Ravandi, Hagop Kantarjian
Dr. Elihu H. Estey (1946-2021). American journal of hematology (2021)
Jorge M Ramos Perez, Keyur P Patel, Sanam Loghavi, Guillermo Garcia-Manero, Gautam Borthakur, Elias Jabbour, William Wierda, Sherry Pierce, Mark Brandt, Steven Kornblau, Tapan Kadia, Naval Daver, Courtney D DiNardo, Nitin Jain, Musa Yilmaz, Nicholas Short, Srdan Verstovsek, Alessandra Ferrajoli, Michael Andreeff, Marina Konopleva, Daniel Rivera, David McCue, Hagop M Kantarjian, Farhad Ravandi
Value of measurable residual disease monitoring in patients with acute promyelocytic leukemia in the era of frontline 'chemotherapy-free' therapy. Leukemia & lymphoma (2021)